AD-118
/ Yuhan Corp
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 22, 2026
A Study to Evaluate the Safety, Pharmacokinetics of AD-118 and AD-1181 in Healthy Adult Subjects
(clinicaltrials.gov)
- P1 | N=74 | Not yet recruiting | Sponsor: Addpharma Inc.
New P1 trial • Cardiovascular • Heart Failure
1 to 1
Of
1
Go to page
1